These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 22290877)

  • 41. Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.
    Fang WB; Jokar I; Chytil A; Moses HL; Abel T; Cheng N
    Clin Exp Metastasis; 2011 Apr; 28(4):351-66. PubMed ID: 21374085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TGF-β signaling in myeloid cells is required for tumor metastasis.
    Pang Y; Gara SK; Achyut BR; Li Z; Yan HH; Day CP; Weiss JM; Trinchieri G; Morris JC; Yang L
    Cancer Discov; 2013 Aug; 3(8):936-51. PubMed ID: 23661553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
    Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
    Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts.
    Xu BJ; Yan W; Jovanovic B; An AQ; Cheng N; Aakre ME; Yi Y; Eng J; Link AJ; Moses HL
    Proteomics; 2010 Jul; 10(13):2458-70. PubMed ID: 20405477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.
    Sung SY; Hsieh CL; Law A; Zhau HE; Pathak S; Multani AS; Lim S; Coleman IM; Wu LC; Figg WD; Dahut WL; Nelson P; Lee JK; Amin MB; Lyles R; Johnstone PA; Marshall FF; Chung LW
    Cancer Res; 2008 Dec; 68(23):9996-10003. PubMed ID: 19047182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aberrant TGF-β Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis.
    Pu H; Begemann DE; Kyprianou N
    Endocrinology; 2017 Jun; 158(6):1612-1622. PubMed ID: 28324007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
    Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL
    Genes Dev; 2006 Nov; 20(22):3147-60. PubMed ID: 17114585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment.
    Lee YC; Gajdosik MS; Josic D; Clifton JG; Logothetis C; Yu-Lee LY; Gallick GE; Maity SN; Lin SH
    Mol Cell Proteomics; 2015 Mar; 14(3):471-83. PubMed ID: 25527621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.
    Yeung TL; Leung CS; Wong KK; Samimi G; Thompson MS; Liu J; Zaid TM; Ghosh S; Birrer MJ; Mok SC
    Cancer Res; 2013 Aug; 73(16):5016-28. PubMed ID: 23824740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
    Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
    Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
    Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.
    Wang L; Xie L; Tintani F; Xie H; Li C; Cui Z; Wan M; Zu X; Qi L; Cao X
    Stem Cells Transl Med; 2017 Feb; 6(2):394-404. PubMed ID: 28191756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II.
    Song K; Krebs TL; Danielpour D
    J Biol Chem; 2006 Mar; 281(12):7765-74. PubMed ID: 16428382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells.
    O'Connor JC; Farach-Carson MC; Schneider CJ; Carson DD
    Mol Cancer Res; 2007 Jun; 5(6):585-603. PubMed ID: 17579118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
    Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.
    Dorai T; Dutcher JP; Dempster DW; Wiernik PH
    Prostate; 2004 Jun; 60(1):1-17. PubMed ID: 15129424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular interactions in the tropism of prostate cancer to bone.
    Sikes RA; Nicholson BE; Koeneman KS; Edlund NM; Bissonette EA; Bradley MJ; Thalmann GN; Cecchini MG; Pienta KJ; Chung LW
    Int J Cancer; 2004 Jul; 110(4):497-503. PubMed ID: 15122581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis.
    Bonfil RD; Chinni S; Fridman R; Kim HR; Cher ML
    Urol Oncol; 2007; 25(5):407-11. PubMed ID: 17826661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.